Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
PepGen
PEPG
$136M
| $394K | ﹤0.01% |
216,824
+81,608
| +60% | +$459K |
|
2977
HighPeak Energy
HPK
$919M
| $393K | ﹤0.01% |
56,922
-1,553
| -3% | -$8.15K |
|
2978
Mexco Energy
MXC
$18.4M
| $392K | ﹤0.01% |
38,314
+957
| +3% | +$10.6K |
|
|
FORTY
2979
Formula Systems
FORTY
$1.75B
| $391K | ﹤0.01% |
3,315
+86
| +3% | +$11.4K |
|
2980
Intellicheck
IDN
$74.3M
| $387K | ﹤0.01% |
55,419
+25,213
| +83% | +$137K |
|
|
LENZ
2981
LENZ Therapeutics
LENZ
$176M
| $381K | ﹤0.01% |
41,874
-71,220
| -63% | -$1M |
|
2982
Gevo
GEVO
$399M
| $379K | ﹤0.01% |
138,855
+75,519
| +119% | +$156K |
|
2983
Optex Systems
OPXS
$78.6M
| $378K | ﹤0.01% |
28,618
+7,138
| +33% | +$98.5K |
|
2984
KE Holdings
BEKE
$17.1B
| $378K | ﹤0.01% |
+25,238
| New | +$433K |
|
2985
Coya Therapeutics
COYA
$101M
| $377K | ﹤0.01% |
95,919
+64,490
| +205% | +$302K |
|
2986
Seer Inc
SEER
$103M
| $373K | ﹤0.01% |
221,916
-13,569
| -6% | -$25.1K |
|
2987
Coffee Holding Co
JVA
$19.8M
| $362K | ﹤0.01% |
85,230
-140
| -0.2% | -$498 |
|
|
NBP
2988
NovaBridge Biosciences American Depositary Shares
NBP
$212M
| $360K | ﹤0.01% |
146,322
-2,130
| -1% | -$7.13K |
|
2989
Data I/O
DAIO
$32.7M
| $356K | ﹤0.01% |
140,679
-39,570
| -22% | -$115K |
|
2990
OptimumBank Holdings
OPHC
$81.8M
| $355K | ﹤0.01% |
71,487
| – | – |
|
2991
ImmuCell
ICCC
$99.9M
| $355K | ﹤0.01% |
56,030
+1,749
| +3% | +$11.2K |
|
2992
AlTi Global
ALTI
$383M
| $354K | ﹤0.01% |
97,681
+30,878
| +46% | +$130K |
|
2993
MaxCyte
MXCT
$115M
| $353K | ﹤0.01% |
502,646
-463,916
| -48% | -$433K |
|
2994
Rafael Holdings
RFL
$119M
| $349K | ﹤0.01% |
278,910
+406
| +0.1% | +$516 |
|
2995
Kentucky First Federal Bancorp
KFFB
$42.2M
| $347K | ﹤0.01% |
80,620
| – | – |
|
2996
Cedar Fair
FUN
$1.83B
| $347K | ﹤0.01% |
+19,530
| New | +$330K |
|
2997
CPS Technologies
CPSH
$84.2M
| $347K | ﹤0.01% |
92,675
+31,209
| +51% | +$138K |
|
2998
NetSol Technologies
NTWK
$51.8M
| $341K | ﹤0.01% |
100,549
-4,696
| -4% | -$15.7K |
|
2999
J.W. Mays
MAYS
$78.6M
| $340K | ﹤0.01% |
8,494
-126
| -1% | -$5.5K |
|
|
FIGR
3000
Figure Technology Solutions
FIGR
$6.51B
| $334K | ﹤0.01% |
+9,851
| New | +$425K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.